Teva Pharmaceuticals has recalled 27,803 bottles of Fluocinolone Acetonide Topical Solution, USP, 0.01% (60 mL), a prescription medication used to treat various skin conditions. This recall was initiated because laboratory testing found the drug was subpotent, meaning it contained less of the active ingredient than required, and had levels of impurities (degradants) that exceeded safety specifications. These bottles were distributed nationwide in the United States and Puerto Rico.
A subpotent medication may not be effective in treating the underlying skin condition, potentially leading to a lack of therapeutic benefit for the patient. Additionally, the presence of impurities beyond established safety limits could cause unexpected side effects or adverse reactions.
Guidance and product return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.